Risk of Bacterial Transmission in Bronchiectasis Outpatient Clinics

Current Pulmonology Reports
Philip J MitchelmoreDavid Hettle

Abstract

The purpose of this review is to discuss the risk of bacterial cross-infection for bronchiectasis patients in the outpatient setting. Cross-infection has primarily been a matter of concern in cystic fibrosis (CF). There is considerable evidence of transmission of pathogens between CF patients, and this has led to guideline recommendations advocating strict segregation policies. Guidelines in bronchiectasis do not specifically address the issue of cross-infection. If cross-infection is prevalent, it may have significant implications for patients and the practical running of specialist care. Multiple UK-based studies have now published evidence of cross-infection with Pseudomonas aeruginosa within cohorts of bronchiectasis patients; however, the risk does not appear to be high. There is also evidence suggesting cross-infection from CF patients to bronchiectasis patients. The current evidence for cross-infection in bronchiectasis is limited, but suggests a small risk with Pseudomonas aeruginosa. Longitudinal studies looking at Pseudomonas aeruginosa and other pathogens are now required.

References

Aug 22, 1992·Lancet·L Millar-JonesM C Goodchild
Jun 1, 1991·Journal of Clinical Microbiology·B TümmlerH von der Hardt
Apr 1, 1986·The Journal of Antimicrobial Chemotherapy·S S PedersenK Rosendal
Jun 1, 1994·Applied and Environmental Microbiology·U RömlingB Tümmler
Mar 4, 1998·The Journal of Antimicrobial Chemotherapy·P Cole
Nov 16, 2004·American Journal of Respiratory and Critical Care Medicine·Andrew M JonesA Kevin Webb
Feb 15, 2005·American Journal of Respiratory and Critical Care Medicine·Amanda L GriffithsDavid S Armstrong
Oct 20, 2006·Clinical Medicine & Research·Ariel Roguin
Dec 1, 2009·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·I J CliftonD G Peckham
Jul 22, 2010·Thorax·M C PasteurUNKNOWN British Thoracic Society Bronchiectasis non-CF Guideline Group
Nov 18, 2010·JAMA : the Journal of the American Medical Association·Shawn D AaronDean Fergusson
Sep 13, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Amanda L GriffithsJohn Massie
Jul 31, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V WatersD S Guttman
Dec 18, 2013·American Journal of Respiratory and Critical Care Medicine·James D ChalmersAdam T Hill
May 27, 2014·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Alan R SmythUNKNOWN European Cystic Fibrosis Society
Jul 16, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Lisa SaimanDavid J Weber
Mar 21, 2015·The European Respiratory Journal·James D ChalmersFrancesco Blasi
Aug 22, 2015·The European Respiratory Journal·Felix C RingshausenJessica Rademacher
Jan 2, 2016·The European Respiratory Journal·Pieter C Goeminne, Anthony De Soyza
Jun 12, 2016·The European Respiratory Journal·Stefano AlibertiUNKNOWN EMBARC Study Group
Apr 28, 2017·The European Respiratory Journal·Yasmin HilliamCraig Winstanley
Sep 11, 2017·The European Respiratory Journal·Eva PolverinoJames D Chalmers

❮ Previous
Next ❯

Citations

Mar 29, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Rebecca E StockwellScott C Bell

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
genotyping

Software Mentioned

ArrayTube

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.